Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 1020-1028

  List, Marcy A ^a   Siston, Amy ^a   Haraf, Daniel ^a   Schumm, Phil ^a   Kies, Merrill ^a   Stenson, Kerstin ^a   Vokes, Everett E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RATING SCALE; SWALLOWING; SYMPTOMATOLOGY; XEROSTOMIA;

EID: 0033008537     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.1020     Document Type: Article

References (49)

1. Wingo PA, Tong T, Bolden F: Cancer statistics, 1995 [published erratum appears in CA Cancer J Clin 45:127-128, 1995]. CA Cancer J Clin 45:8-30, 1995
2. Vokes EE, Weichselbaum RR. Lippman SM. et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
3. Dimery IW. Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993
4. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
5. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
6. Vokes EE, Kies MS, Haraf DJ, et al: Intensive concomitant chemoradiotherapy (CT/XRT) for head and neck cancer (HNC): High locoregional control and organ preservation (OP) rates. Proc Am Soc Clin Oncol 17:385, 1998 (abstr 1485)
7. Al-Sarraf M, Leblanc M, Shanker PG. et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
8. Wendt TG, Grabenbauer GG, Rödel CM, et al: Simultaneous radiotherapy vs radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1314, 1998
9. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 14:8838-8847, 1996
10. Munro A: An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
11. Merlano M, Benasso RC, Rosso R: Five-year update of a randomized trial of alternating radiotherapy and chemoradiotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
12. Brizel DM, Albers JE, Samuel RF, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
13. th International Conference on Head and Neck Cancer, Toronto, Canada: The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996, p 161
14. Bourhis J, Pignon JP, Designé L, et al: Meta-analysis of chemotherapy in head and neck cancer (mach-nc): (1) Loco-regional treatment vs same treatment + chemotherapy (CT). Proc Am Soc Clin Oncol 17:386, 1998 (abstr 1486)
15. Fountzilas G, Kosmidis P, Zamboglou N, et al: Does substitution of surgery with induction chemotherapy preserve organ function in inoperable head and neck cancer? A retrospective analysis of 73 cases. J Chemother 6:672-678, 1994
16. Rathmell AJ, Ash DV, Howes M, et al: Assessing quality of life in patients treated for advanced head and neck cancer. Clin Oncol 3:10-16, 1991
17. Gamba A, Romano M, Grosso LM, et al: Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck 14:218-223, 1992
18. Logemann JA, Pauloski BR, Rademaker AW, et al: Speech and swallow function after tonsil/base of tongue resection with primary closure. J Speech Hear Res 36:918-926, 1993
19. Karim ABMF, Kralendonk JH, Njo KH, et al: Radiation therapy for advanced (T3T4NO-N3M0) laryngeal carcinoma: The need for a change of strategy: A radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 13:1625-1633, 1987
20. List MA, Ritter-Sterr CA, Baker TM, et al: Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck 18:1-10, 1996
21. Silverman S: Oral cavity toxicity, in John MJ, Flam MS, Legha SS, et al (eds): Chemoradiation: An Integrated Approach to Cancer Treatment. Philadelphia, PA, Lea & Febiger, 1993, pp 511-523
22. Teichgraeber J, Browman J, Goepfert H: Functional analysis of treatment of oral cavity cancer. Arch Otolaryngol Head Neck Surg 112:959-965, 1986
23. Bjordal K, Kaasa S, Mastekaasa A: Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Oncol Biol Phys 28:847-856, 1994
24. Rapoport Y, Kreitler S, Chaitchik S, et al: Psychosocial problems in head-and-neck patients and their change with time since diagnosis. Ann Oncol 4:69-73, 1993
25. Breitbart W, Holland JC: Head and neck cancer, in Holland JC, Rowland JH (eds): Handbook of Psychooncology: Psychological Care of the Patient With Cancer. New York, NY, Oxford Press, 1989, pp 232-239
26. Jones E, Lund VJ, Howard DJ, et al: Quality of life of patients treated surgically for head and neck cancer. J Laryngol Otol 106:238-242, 1992
27. Bjordal K, Kaasa S: Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer 71:592-597, 1995
28. Harrison LB, Zelefsky MJ, Armstrong JG, et al: Performance status after treatment for squamous cell cancer of the base of tongue: A comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys 30:953-957, 1994
29. McDonough EM, Varvares MA, Dunphy FR, et al: Changes in quality of life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck 18:487-493, 1996
30. List MA, Mumby P, Haraf D, et al: Performance and quality of life outcomes in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6:274-284, 1997
31. List MA, Haraf D, Siston A, et al: A prospective study of quality of life/performance outcome in head and neck cancer patients on an intensive chemoradiotherapy protocol. Proc Am Soc Clin Oncol 16:389, 1997 (abstr 1390)
32. Kies MS, Haraf DJ, Mittal K, et al: Intensive combined therapy with C-DDP, 5-FU, hydroxyurea, and BID radiation (C-FHX) for stage IV squamous cancer (SCC) of the head and neck. Proc Am Soc Clin Oncol 15:314, 1996 (abstr 886)
33. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutics in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. Symposium, Microbiology Section, New York Academy of Medicine. New York, NY, Columbia University, 1949, pp 191-205
34. List MA, Ritter-Sterr CA, Lansky SB: A performance status scale for head and neck cancer patients. Cancer 66:564-569, 1990
35. List MA, D'Antonio LL, Cella DF, et al: The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale: A study of utility and validity. Cancer 77:2294-2301, 1996
36. Browman GP, Levine MN, Hodson DI, et al: The Head and Neck Radiotherapy Questionnaire: a morbidity/quality of life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 11:863-872, 1993
37. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
38. Cella DF: Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3). Chicago, IL, Rush Medical Center, 1994
39. Schluchter MD: Methods for the analysis of informatively censored longitudinal data. Stat Med 11:1861-1870, 1992
40. Mallows CL: Some comments on Cp. Technometrics 15:661-675, 1973
41. Lydick E, Epstein RS: Interpretation of quality of life changes. Qual Life Res 2:221-226, 1993
42. Finlay PM, Dawson F, Robertson AG, et al: An evaluation of functional outcome after surgery and radiotherapy for intraoral cancer. Br J Maxillofac Surg 30:14-17, 1992
43. De Boer MF, Pruyn JFA, van den Borne B, et al: Rehabilitation outcomes of long-term survivors treated for head and neck cancer. Head Neck 17:503-515, 1995
44. Bundgaard T, Tandrup O, Elbrond O: A functional evaluation of patients treated for oral cancer. Int J Oral Maxillofac Surg 22:28-34, 1993
45. Harrison LB, Zelefsky MJ, Pfister DG, et al: Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 9:169-175, 1997
46. Langius A, Björvell H, Lind M: Oral- and pharyngeal-cancer patients' perceived symptoms and health. Cancer Nurs 16:214-221, 1993
47. Browman GP, Wong G, Hodson I, et al: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159-163, 1993
48. Hammerlid E, Bjordal K, Ahlner-Elmquist M, et al: Prospective, longitudinal quality of life study of patients with head and neck cancer: A feasibility study including the EORTC QOLQ C30. Otolaryngol Head Neck Surg 116:666-673, 1997
49. Baile WF, Gibertini M, Scott L, et al: Depression and tumor stage in cancer of the head and neck. Psycho One 1:15-24, 1992